Pilot Study Evaluating the Safety and Efficacy of Open-Label Olanzapine

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00194064
Recruitment Status : Terminated (Slow enrollment)
First Posted : September 19, 2005
Last Update Posted : October 4, 2016
Eli Lilly and Company
Information provided by (Responsible Party):
Joseph Calabrese, MD, University Hospitals Cleveland Medical Center

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : February 2006
  Actual Study Completion Date : February 2006